DOI:

Launching a new journal dedicated to interventional cardiology is a great challenge.

Antoine Lafont*

Dear colleagues,

EuroIntervention is the culmination of a major decision to promote for the first time in Europe the fantastic potential in the field of interventional cardiology. Europe has been and remains the most creative frontline community in interventional cardiology. This deserves a dedicated specific journal in order to voice the unique spirit of our European leaders. Therefore EuroPCR and the ESC via the Working Group of Interventional Cardiology have taken the decision to harness their energy and talents to deliver a strong, homogeneous message. The aim is to strengthen this collaboration with the creation of EuroIntervention and is the first statement of a common strategy to improve education and science in the field of interventional cardiology.

The co-editorship mirrors the boards of EuroPCR, ESC, and the WG on Interventional Cardiology (WG10). The International Editorial Board includes worldwide recognised leaders, and the readership is currently more than 10 000. This provides us the opportunity to inform and debate using the journal as our common medium.

I would like to take this opportunity, in this first WG10 column, to announce that the Working Group on Interventional Cardiology will officially launch in Stockholm, during the ESC’s annual meeting, six fellowship grants sponsored by major industrial partners, Lilly (two grants), Boston, Medtronic, Cordis, and EUROPCR. This is a clear sign of prioritising our leadership in education in order to identify and support the next generation of interventional cardiologists.

The fellowship grants are targeted at cardiologists younger than 36 years with a previous experience of at least 300 coronary angiograms. We request that training centres can confirm that on the basis of their ability to perform in excess of 600 percutaneous coronary interventions but are also dedicated and personally committed to practical training in the fellowship programme.

The aim of the European fellowship programme is not only to focus on an excellent standard of practical training but also to supervise and aid fellows in clinical science, which will be translated for example into active participation in the research activities of their center, to be expressed in abstract presentation at the annual meetings of the ESC, clinical cases at EUROPCR, and publications in EuroIntervention.

Once the year long fellowship is completed, the fellow will be involved in activities in the working group, and will be supported in developments on a national and European level. These fellowship grants will assist us in creating together a new and dynamic generation of interventional cardiology in Europe. Further practical information will be available on the website of the working group.

Volume 1 Number 2
Aug 20, 2005
Volume 1 Number 2
View full issue


Key metrics

Suggested by Cory

Editorial

10.4244/EIJ-E-25-00027 Jul 7, 2025
Antithrombotic strategies after TAVI in light of cerebral microembolism
Dangas G and Nicolas J
free

Editorial

10.4244/EIJ-E-25-00028 Jul 7, 2025
The challenge of interpreting comparative TAVI studies
Rosseel L et al
free

Editorial

10.4244/EIJ-E-25-00024 Jul 7, 2025
The new balloon-expandable Myval transcatheter heart valve: only good news?
Pibarot P and Van Belle E
free

Debate

10.4244/EIJ-E-25-00019 Jul 7, 2025
Colchicine benefits are overestimated and current recommendations are too strong: pros and cons
Bainey K and Rossello X

Original Research

10.4244/EIJ-D-24-00966 Jul 7, 2025
Intra- versus supra-annular self-expanding transcatheter heart valves in small aortic annuli
Yamamoto M et al

Original Research

10.4244/EIJ-D-24-01112 Jul 7, 2025
Four-year durability of the Myval balloon-expandable transcatheter aortic valve
Jain A et al

Research Correspondence

10.4244/EIJ-D-24-01113 Jul 7, 2025
Restenosis patterns after percutaneous coronary intervention with drug-coated balloons for de novo coronary lesions
Matsuda K et al
Trending articles
172.05

Focus article

10.4244/EIJY19M08_01 Jan 17, 2020
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an update
Glikson M et al
free
64.8

State-of-the-Art

10.4244/EIJ-D-24-00066 Apr 21, 2025
Management of complications after valvular interventions
Bansal A et al
free
42

Original Research

10.4244/EIJ-D-25-00331 May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
26.5

Expert Review

10.4244/EIJ-D-24-00535 May 5, 2025
Catheter-based techniques for pulmonary embolism treatment
Costa F et al
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved